Skip to main content
Clinical Trials/IRCT2015062115587N9
IRCT2015062115587N9
Completed
Phase 2

Evaluation of the therapeutic effect of oral administration of cinnamon on Non-alcoholic steatohepatitis (NASH)

Vice –Chancellor of Shiraz University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
on-alcoholic steatohepatitis.
Sponsor
Vice –Chancellor of Shiraz University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice –Chancellor of Shiraz University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria of the study:
  • ALT level higher than 65U/L; Diagnosed fatty liver in ultrasonography; No alcohol and drug abuse; No history of chemotherapy in the past years; No history of other chronic liver diseases such as hepatitis B and hepatitis C, cirrhosis, bile diseases, autoimmune diseases, cancer and any genetic disorder that effects liver function such as Wilson’s disease; No history of lipid\-lowering drug use; No pregnancy and breast\-feeding; No use of vitamin E supplements; No use of drugs that caused fatty liver, like tetracycline, vitamin A, methotrexate, amiodarone, tamoxifen, etc.; No history of use of hepatotoxic drugs in the last 6 months; No long\-term use of herbal drugs
  • Exclusion criteria:
  • If the patient indicates hypersensitivity reactions to cinnamon, becomes pregnant or not interested, and also if the level of liver enzymes rises at the end of the forth week due to cinnamon consumption, the patient will be excluded from the study.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials